A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced Solid Tumors|Solid Tumors|Ovarian Cancer|Breast Cancer|Prostate Cancer|NSCLC|Pancreatic Cancer|Colorectal Cancer
Interventions: DRUG: TALZENNA capsule|DRUG: Talazoparib soft gel capsule|DRUG: Talazoparib soft gel capsule
Sponsor: Pfizer